Product NewsDrug discovery > Lead Discovery TopoTarget initiates pivotal Phase II trial with Savicol™ for FAP (an inherited pre-disposition to develop colon cancer)
Product NewsDrug discovery > Lead Discovery Hybrigenics acquires worldwide rights to inecalcitol, a vitamin D analogue
Product NewsDrug discovery > Clinical Development ARDANA’S NOVEL TESTOSTERONE CREAM REMAINS ON TRACK FOR Q4 2007 LAUNCH FOLLOWING PRE-IND MEETING WITH US FDA.
Product NewsDrug discovery > Clinical Development TopoTarget and CuraGen initiate Phase II Trial with PXD101 for T-Cell Lymphomas (TCLs)
Product NewsDrug discovery > Clinical Development GemacBio announces the successful conclusion of Phase IIa clinical trials for its new molecule designed to treat multiple sclerosis
Product NewsLife Sciences SYMPHOGEN’S SUCCESS IN MANUFACTURING CONSISTENT BATCHES OF POLYCLONAL ANTIBODIES FOR CLINICAL TRIALS ATTRACTS NEW USD 25 MILLION INVESTMENT
